Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension (2015)
- Autores:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1093/eurheartj/eht549
- Assuntos: EVENTO ADVERSOS A MEDICAMENTOS; FÁRMACOS (SISTEMA CARDIOVASCULAR); HIPERCOLESTEROLEMIA (TERAPIA)
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: European heart journal
- ISSN: 0195-668X
- Volume/Número/Paginação/Ano: v. 36, n. 9, p. 566-575, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: cc-by-nc
-
ABNT
SANTOS, Raul D. et al. Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension. European heart journal, v. 36, n. 9, p. 566-575, 2015Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/eht549. Acesso em: 17 abr. 2024. -
APA
Santos, R. D., Duell, P. B., East, C., Guyton, J. R., Moriarty, P. M., Chin, W., & Mittleman, R. S. (2015). Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension. European heart journal, 36( 9), 566-575. doi:10.1093/eurheartj/eht549 -
NLM
Santos RD, Duell PB, East C, Guyton JR, Moriarty PM, Chin W, Mittleman RS. Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension [Internet]. European heart journal. 2015 ; 36( 9): 566-575.[citado 2024 abr. 17 ] Available from: https://doi.org/10.1093/eurheartj/eht549 -
Vancouver
Santos RD, Duell PB, East C, Guyton JR, Moriarty PM, Chin W, Mittleman RS. Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension [Internet]. European heart journal. 2015 ; 36( 9): 566-575.[citado 2024 abr. 17 ] Available from: https://doi.org/10.1093/eurheartj/eht549 - Foi com muita satisfação que recebemos o convite dos ...[Apresentação]
- Relation of Uric Acid to Serum Levels of High-Sensitivity C-Reactive Protein, Triglycerides, and High-Density Lipoprotein Cholesterol and to Hepatic Steatosis
- Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment
- Elevated uric acid, the metabolic syndrome and cardiovascular disease [Editorial]: cause, consequence, or just a not so innocent bystander?
- Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta]
- Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease
- A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
Informações sobre o DOI: 10.1093/eurheartj/eht549 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas